Genomics In Cancer Care Market Is Expected To Grow At CAGR Of 17.3% Over The Forecast Period 2012-2022

Global Genomics In Cancer Care Market is expected to reach USD 9.22 billion by 2022, according to a new report by Grand View Research, Inc. Increasing prevalence of cancer coupled with adoption of next generation sequencing for the diagnosis & treatment is expected to fuel the market with future growth opportunities. Increasing incidences of cancer triggers the demand for cost effective and accurate diagnostics in coming years. 

In addition, increasing demand for personalized medicines in molecular characterization of cancer to identify therapeutic targets is the factor attributing towards the market growth. Similarly, factors such as cost reduction in genome sequencing, growing healthcare expenditure levels and development of effective diagnostics & therapeutic procedures for cancer are responsible for the potential growth of genomics in cancer care. 

Full Research Report on Global Genomics In Cancer Care Market Analysis:  http://www.grandviewresearch.com/industry-analysis/genomics-in-cancer-care-market

Further key findings from the study suggest:

• Instrument segment dominated the overall market in terms of revenue share as of 2014 and accounted for 33.4% of market owing to high cost associated with it. Whereas, consumables are most widely used product segment in genome testing as they are indispensible component and frequently required to perform the test.
• Demand for services such as next generation sequencing, PCR and other such as cancer risk management & genetic testing are expected to grow over the forecast period due to increasing outsourcing activities to perform genome analysis. High cost of performing genetic tests and growing awareness pertaining to associated benefits with the use of these technologies are high impact rendering drivers for this segment.
• Drug discovery and development segment is expected to show lucrative CAGR of 17.6% during the forecast period owing to increasing demand for effective treatment for cancer and growing investment in biomedicines by manufacturers for the development of novel products. 
• Genome sequencing held the dominant share of technology segment as it is most prominently used for diagnosis due to associate benefits such as faster and accurate method. It is expected to show significant growth rate of 17.5% in coming years owing to remarkable decrease in the cost for genome sequencing and increasing adoption rates.
• The cancer research segment held the largest share of 34.1% in 2014 due to increasing demand for faster & accurate diagnostic methods to treat variety of cancer. Other use such as commercial adoption of genetic testing is expected to be fastest growing segment owing to increasing demand of cancer genomic testing to fulfill unmet needs in healthcare sector.
• Some key players operating in this market include Beckman Coulter Inc., Illumina, Inc, Affymetrix, Roche Diagnostics, Agilent Technologies, Cancer Genetics Inc., Danaher Corporation, Bio-Rad Labs, Pacific Biosciences, Quest Diagnostics, Sigma Aldrich, Luminex, Thermo Fisher scientific, Oxford Gene Technology., PerkinElmer, Qiagen, and GE Healthcare.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the Global Genomics In Cancer Care Market on the basis of application and region: 

Global genomics in cancer care product outlook (Revenue, USD Million, 2012 - 2022)

• Instruments 
• Consumables
• Services

Global genomics in cancer care application (Revenue, USD Million, 2012 - 2022)

• Diagnostics
• Personalized medicine
• Drug discovery & development
• Research

Global Genomics in cancer care technology  Outlook (Revenue, USD Million, 2012 - 2022)

• Genome sequencing
• PCR
• Microarrays
• Nucleic acid extraction & purification
• Other

Genomics in cancer care regional outlook (Revenue, USD Million, 2012 - 2022)

• North America
• U.S
• Canada
• Europe
• U.K 
• Germany
• Asia Pacific
• Japan
• China
• India
• Latin America
• Mexico
• Brazil
• MEA
•  South Africa

View Press Release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-genomics-in-cancer-care-market                 

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Genome Editing Market Analysis By Technology, Application, End-Use, Application and Segment Forecast Up To 2025

Global Genome Editing Market is anticipated to reach USD 8.1 billion by 2025, according to a new report by Grand View Research, Inc. Key drivers attributing to the expansion include early applications of DNA editing to therapeutics. Use of the technology for the disease eradication through direct correction of disturbances in normal physiology, engineering the immune response, and alteration of pathogen targets in the host is anticipated to drive the market with substantial opportunities.

The ability of genome editing therapies to offer a significant improvement over current treatment options is important in enabling editing technologies to capture significant revenue share. Improved efficacy, reduced side effects, and the potential for cure for specific diseases, can be attributed to induce growth in the coming years. 

Moreover, technological advancements with respect to the development of novel vectors for delivery is anticipated to fuel growth in the coming years. Rising competition amongst the operating entities in order to gain the larger share of revenue is also responsible for the projected growth. These companies leverage industry collaborations for the acceleration of diversified product pipelines. 

Full Research Report on Global Genome Editing Market Analysis: http://www.grandviewresearch.com/industry-analysis/genome-editing-market

Further Key Findings from the Report Suggest:

• There has been great excitement surrounding the highly adaptable CRISPR technology.
• The increased ease of retargeting and the ability to multiplex goes a long way toward explaining the speed with which CRISPR-centric companies have sprung up.
• Ex-vivo mode of delivery accounted for the largest share of the revenue.
• Therapy through ex-vivo mode of delivery allow the control over the specific dosage of therapeutic molecules delivered to cells.
• Cell line engineering dominated with respect to revenue generation owing to the high utilization of technology in stem cell engineering.
• There is comparatively, higher adoption of the technology in the biotechnology and pharmaceutical organizations for the purpose of therapeutic development.
• Availability of other services such as gRNA library production and screening service along with editing is anticipated to propel growth in the outsourcing services.
• Asia Pacific is anticipated to witness fastest growth over the forecast period owing to rising penetration of technology in comparatively immature market.
• Key players contributing in this market are Thermo Fisher Scientific, Inc., Sangamo, Editas Medicine, Recombinetics, Inc, Sigma Aldrich Corporation, CRISPR THERAPEUTICS, Intellia Therapeutics, Inc., Caribou Biosciences, Inc.
• These participants are capitalizing on unique advantages offered by the nuclease technology, they are working on.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the Global Genome Editing Market on the basis of technology, delivery method, application, end-use, service, and region: 

Molecular Scissors/Genome Editing Technology Outlook (Revenue, USD Million, 2014 - 2025)

• (CRISPR)/Cas9
• TALENs/MegaTALs
• ZFN
• Others

Molecular Scissors/Genome Editing Delivery Method Outlook (Revenue, USD Million, 2014 - 2025)

• Ex-Vivo
• In-Vivo

Molecular Scissors/Genome Editing Application Outlook (Revenue, USD Million, 2014 - 2025)

• Cell Line Engineering
• Animal Genetic Engineering
• Plant Genetic Engineering
• Other Applications

Molecular Scissors/Genome Editing End-use Outlook (Revenue, USD Million, 2014 - 2025)

• Biotechnology & Pharmaceutical Companies
• Academic & Government Research Institutes
• Contract Research Organizations

Molecular Scissors/Genome Editing Service Outlook (Revenue, USD Million, 2014 - 2025)

• Contract
• In-house

Molecular Scissors/Genome Editing Service Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• Middle East and Africa (MEA)
• South Africa

View Press Release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-genome-editing-market                

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Genotyping Market Analysis By Product, Technology, Application, And Segment Forecast Up To 2024

Global Genotyping Market is expected to reach USD 37.1 billion by 2024 according to a new report by Grand View Research, Inc. The increasing demand for genotyping tests to evaluate drug efficacy and safety is one of the major drivers for the genotyping market. Genotyping tests are widely used in selecting a highly responsive, patient population subset against a specific drug candidate before initiating clinical trials. The rising need for affordable genotyping services coupled with the high demand for personalized medicines is also expected to propel the market growth. 

Major pharmaceutical companies are collaborating with diagnostic manufacturers for the development of novel biomarker-based therapeutics. Significant opportunities for the growth of this market are anticipated due to the above-mentioned collaborative initiatives. 

The increasing awareness for prenatal genetic testing pertaining to early detection of chromosomal abnormalities in the high-risk population, the introduction of technological advancements, and the increasing R&D funding are the other factors accentuating the market growth over the forecast period. 

Full Research Report on Global Genotyping Market Analysis:
http://www.grandviewresearch.com/industry-analysis/genotyping-market

Further key findings from the study suggest:

• The reagents and kits segment dominated the product segment in 2015. Extensive usage of reagents for research activities and the wide applicability of the genotyping tests in disease diagnosis and validation are the factors responsible for its large share
• The reagent and kits segment is also anticipated to witness the highest growth over the forecast period. The major factors responsible for the lucrative growth of this segment are a high amount of R&D activities undertaken by research and academic institutes for the development of novel genetic biomarkers.
• In 2015, the polymerase chain reaction technology captured a significant market share owing to the higher acceptance levels by researchers and the introduction of technologically advanced and user-friendly products
• The diagnostic center was one of the largest segments with a market share of over39.0% in 2015. The rising demand for genotyping tests coupled with the high awareness for genetic disorders is a key driver for its large market share. Personalized medicine is expected to grow at a significant growth rate over the forecast period due to the increasing demand for the efficient and fast-acting therapeutics under the precision medicine category.
• North America held the largest share of thegenotyping market in 2015.The rising healthcare expenditure, established R&D infrastructure, and the increasing awareness among doctors for hereditary genetic disorders are the factors contributing to the large share.
• Asia Pacific is anticipated to be the fastest growing regional segment during the forecast period. The introduction of favorable government initiatives and programs, the geographical expansion of major players in this area, and the growing target population base are some of the factors expected to push forward the market growth.
• The key players include Affymetrix, Inc., Agilent Technologies, Inc., Genewiz, Inc., Fluidigm Corporation, GE Healthcare GmbH, Illumina, Inc., Thermo Fisher Scientific, Inc., Qiagen NV, and Roche Diagnostics
• In April 2016, Siemens Healthcare GmbH and Thermo Fisher Scientific, Inc. declared a strategic collaboration for the development of an advanced and integrated genotyping platform. This agreement aimed to introduce enhanced flexibility and customizability to their molecular testing solutions. 

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the Global Genotyping Market on the basis of product, technology, application, and region:

Genotyping Market Product Outlook, by Revenue (USD Million, 2013 - 2024)

• Instruments
• Reagents and kits
• Services

Genotyping Market Technology Outlook, by Revenue (USD Million, 2013 - 2024)

• Polymerase Chain Reaction(PCR)
• Capillary Electrophoresis
• Mass Spectrometry
• Sequencing
• Microarray
• Other

Genotyping Market Application Outlook, by Revenue (USD Million, 2013 - 2024)

• Diagnostics
• Drug Discovery and Development
• Personalized Medicine
• Academic Research
• Agriculture
• Others

Genotyping Market Regional Outlook, by Revenue (USD Million, 2013 - 2024)

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• Japan
• China
• Latin America
•  Brazil
• MEA
• South Africa

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-genotyping-market              

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Microtome Market Is Anticipated To Growing At A CAGR Of 4.6% During Forecast Period 2014-2025

Global Microtome Market is expected to reach USD 73.5 million by 2025, according to a new report by Grand View Research, Inc. Growing awareness about early diagnosis of chronic diseases and increasing demand for technologically advanced diagnostic equipment are some of the key factors anticipated to drive the microtome market.

According to the estimates of Laboratory Economics, in 2012, over USD 20 billion was spent on laboratory mergers between 1996 and 2011. In 2011, approximately USD 3.5 billion was spent on laboratory mergers. Increasing worldwide geriatric population, growing healthcare expenditure, and rising patient awareness regarding early disease diagnosis are some of the key factors expected to propel the tissue diagnostics market. This, in turn, is likely to boost demand for tissue slicing equipment. However, reimbursement cuts and hospital consolidation are some of the factors expected to hamper growth.

Although the U.S. ranks first in terms of per capita healthcare spending, spending on clinical laboratories is significantly lower as compared to other healthcare aspects. Moreover, overall growth in the clinical laboratory market is majorly dependent on demographic factors, technological, medical, & scientific advancements, and disease burden specific to that region. Developed economies, such as the U.S., Germany, Japan, Canada, and France, have huge R&D budgets, higher technological advancements, and more awareness regarding various health aspects as compared to developing economies. This is likely to account for majority of the share in these regions.

Growing number of histopathology laboratories, high growth potential of anatomical pathology labs in emerging economies, and rising awareness regarding digital pathological systems are some key attributes that can provide new opportunities to players. Adoption rate of histology equipment is expected to gain substantial momentum owing to growing usage of technologically advanced biomarkers in diagnosing various diseases such as cancer and other infectious diseases.

Full Research Report on Global Microtome Market Analysis:
http://www.grandviewresearch.com/industry-analysis/microtome-market

Further Key Findings From the Report Suggest:

• The global microtome market size was estimated at USD 48.6 million in 2016 and is expected to grow at a CAGR of 4.6% from 2017 to 2025
• The microtome devices segment emerged as the largest product segment in 2016
• Microtome accessories such as blades, blade holders, and clamps is anticipated to witness fastest growth over the next eight years
• The Asia Pacific region is anticipated to witness lucrative growth over the next decade. It is expected to grow at a CAGR of 9.2% over the forecast period
• Some of the key players are LLS ROWIAK LaserLabSolutions GmbH; Leica Biosystems Nussloch GmbH; Sakura.; MEDITE GmbH; SLEE medical GmbH; Boeckeler Instruments, Inc.; Nanolytik; S.M. Scientific Instruments Pvt. Ltd.; MICROS Austria Produktions-und Handelsges.m.b.H; AGD Biomedicals (P) Ltd.; Alltion; Amos Scientific Pty Ltd; and Thermo Fisher Scientific

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Global Microtome Market on the basis of product, technology, and region:

Product Outlook (Revenue, USD Million, 2014 - 2025)

• Microtome Devices
• Rotary Microtome
• Vibrating Microtome
• Other Microtomes
• Accessories

Technology Outlook (Revenue, USD Million, 2014 - 2025)

• Fully Automated
• Semi-Automated
• Manual

Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• Japan
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• South Africa

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-microtome-market             

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Microporous Insulation Market Analysis By Product, Application, Region And Segment Forecast Up To 2025

Global Microporous Insulation Market is expected to reach USD 184.8 Million by 2025, according to a new report by Grand View Research, Inc. The rapid growth of the end-use industries has been a major factor driving the global market.

Energy & power industry has been witnessing significant growth in the power generation from renewable energy. Thermal insulation is one of the vital requirements during manufacturing on account of high levels of heat emission by gas and steam turbines. The superior properties of microporous insulation allow efficient protection of the equipment during power generation. This is likely to have a positive impact on the demand for the product in this sector.

High product cost is expected to be the major market restraint over the forecast period. High manufacturing cost on account of low industrial production capacity is anticipated to restrict market growth.

The product is considered expensive for utilization in price sensitive sectors such as commercial, automotive, and industrial applications. However, companies including Thermodyne have been trying to develop products which can lead to energy conservation and weight reduction, thereby compensating the high cost.

Full Research Report on Global Microporous Insulation Market: http://www.grandviewresearch.com/industry-analysis/microporous-insulation-market

Further key findings from the report suggest:

• Flexible panel segment is expected to grow at fastest CAGR of 5.1% due to its wide range of application in oil & gas industry
• Industrial segment emerged as the largest application in 2016 and is expected to grow at a CAGR of 4.7% from 2017 to 2025 on account of high utilization of the product in metal, iron & steel, nonferrous metals, and ceramic industries
• Oil & gas industry is expected to grow at fastest CAGR of 6.5% in Middle East & Africa region due to presence of huge oil reserves
• Europe accounted for the largest market share in 2016 and is expected to grow at a CAGR of 3.8% from 2017 to 2025. The industry is expected to witness fastest growth in demand from aerospace & defense sector in the region.
• The Asia Pacific market is expected to witness fastest CAGR of 6.0% from 2017 to 2025 on account of high GDP growth, rising population, and rapid industrialization in the region
• Market players have been adopting mergers & acquisition and expansion as their key strategic initiatives over the past years. For instance, in August 2011, Unifrax LLC acquired three North American vacuum forming businesses which are, VacuForm Incorporated ("VFI"), Refractory Specialties Incorporated ("RSI"), and specialty Ceramics Incorporated ("SCI").
• In December 2013, Promat International Nv started a new factory in North America to expand its product offerings in passive fire protection (PFP) and high-performance insulation (HPI)

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/advanced-materials

Grand View Research has segmented the Global Microporous Insulation Market on the basis of product, application, and region:

Microporous Insulation Product Outlook (Revenue, USD Thousand, 2014 - 2025)

• Rigid boards & panels
• Flexible panels
• Others

Microporous Insulation Application Outlook (Revenue, USD Thousand, 2014 - 2025)

• Industrial
• Energy & power
• Oil & gas
• Aerospace & defense
• Others

Microporous Insulation Regional Outlook (Revenue, USD Thousand, 2014 - 2025)

• North America
• U.S.
• Canada
• Mexico
• Europe

• Germany
• UK
• France

• Asia Pacific

• China
• India
• Japan

• Central & South America

• Brazil

• Middle East & Africa

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-microporous-insulation-market            

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Glyphosate Market Demand Was Over 700 Kilo Tons In 2013, Which Is Expected To Exceed 1,000 Kilo Tons By 2020

Global Glyphosate Market is expected to exceed USD 8.50 billion by 2020, according to a new study by Grand View Research, Inc. GM crops have witnessed high penetration, on account of benefits such as high yield and disease resistance. The amount of glyphosate added to major genetically modified crops has been increasing over the past few years. This is expected to drive the global glyphosate market over the forecast period. High demand for minimum tillage as well as no-tillage systems is also expected to fuel the market over the next six years. Considerable environmental and health concerns have led to stringent regulations on glyphosate usage, which may act as a restraint to industry growth.

Full Research Report On Global Glyphosate Market Analysis:
http://www.grandviewresearch.com/industry-analysis/glyphosate-industry

Further key findings from the study suggest:

• Global glyphosate demand was over 700 kilo tons in 2013, which is expected to exceed 1,000 kilo tons by 2020.
• Conventional crops dominated global market volume in 2013; glyphosate is used two to three weeks before sowing crops such as wheat, sorghum, sunflower, etc. This aids in significant tillage reduction along with efficient weed control. GM crops are expected to witness high growth over the forecast period, primarily due to growing adoption in Latin America, China and India.
• Asia Pacific was the largest regional market in 2013; North America accounted for over 25% of the global market volume in the same year. GM crop adoption coupled with arable land availability in China and India is expected to drive the Asia Pacific glyphosate market over the next six years.
• Major industry participants include Monsanto, Syngenta, Nufarm, Dow AgroSciences and DuPont. Other companies mainly include BASF, Bayer and a large number of Chinese manufacturers. Key players have targeted weed management systems development, which help lower adverse environmental impact and control weeds through different modes as compared to traditional glyphosate application.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/agrochemicals-and-fertilizers

Grand View Research has segmented the Global Glyphosate Market on the basis of application and region:

    • Glyphosate Application Outlook (Volume, Kilo Tons & Revenue, USD Million; 2012 - 2020)
            • Conventional Crops
            • GM Crops
    • Glyphosate Regional Outlook (Volume, Kilo Tons & Revenue, USD Million; 2012 - 2020)
            • North America
                    • U.S.
                    • Mexico
            • Europe
                    • Germany
                    • UK
            • Asia Pacific
                    • China
                    • India
                    • Japan
            • RoW
                    • Brazil

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-glyphosate-market               

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Glycobiology Market Analysis By Product Application, End-Use, And Segment Forecast Up To 2025

Global Glycomics/Glycobiology Market is expected to reach USD 2.1 billion by 2025, according to a new report by Grand View Research, Inc. Increasing investment in R&D by research institutes and pharmaceutical & biotechnology companies has been a major factor driving market growth. In addition, technological advancement has led to increased demand for advanced glycomics products for drug discovery & development, diagnostics, and oncology research. 

Escalating popularity of personalized medicines for the treatment of several severe chronic diseases and genetic disorders is another major factor contributing toward the growth. Personalized medicines involve the application of glycomics for the study of structure and function of glycans that are attached to biomolecules. Glycans play a crucial role in modulating various biological processes and their assessment can help determine the susceptibility to diseases & response to treatment. Thus, application of glycobiology products is expected to rise in near future, owing to their high potential in personalized medicine.

Untapped opportunities in developing regions, including Asia Pacific and Africa, are another major factor supporting the growth of the glycomics market. Glycomics research is important for comprehensive study of glycomes to understand the cellular signaling pathways, cell functions, genetic structure, and physiological & pathological aspects. Glycomics research has become more popular these days due to its advantages over genomic/proteomic analysis that cannot be used to study many pathological processes. Thus, the demand for advanced glycomics products by researchers and healthcare professionals is expected to fuel the sector growth.

Full Research Report On Global Glycomics/Glycobiology Market Analysis: http://www.grandviewresearch.com/industry-analysis/glycobiology-market

Further Key Findings From the Report Suggest:

• Enzymes segment is the fastest growing segment of the glycobiology market in 2016, due to its huge application in research & diagnostics and repetitive purchase of these products
• In the application segment, drug discovery & development accounted for the largest revenue share in 2016, owing to the growing focus on novel drug development and demand for personalized medicines
• The academic and research institutes dominated in terms of revenue in 2016, owing to the large focus on glycobiology research and proteomics study
• The North America glycobiology market is the leading regional sector and expected to dominate the market during forecast period
• Existence of large number of research laboratories, pharmaceutical companies, and biotechnology companies in North America region is the major reason for the high demand for glycobiology products in this region
• The Asia Pacific glycobiology market is expected to grow at the highest growth rate during the forecast period
• Some of the major players include Danaher; ProZyme; Shimadzu Corporation; Agilent Technologies; Bruker; Merck KGaA; Takara Bio, Inc.; New England Biolabs; ThermoFisher Scientific, Inc.; and Waters Corporation

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the Global Glycomics/Glycobiology Market on the basis of product, application, end-use, and region:

Glycomics/Glycobiology Product Outlook (Revenue, USD Million; 2014 - 2025)

• Instruments
• Mass spectrometers
• HPLC
• MALDI-TOF
• Array systems
• Others
• Reagents
• Glycoproteins
• Monosaccharides
• Oligosaccharides
• Others
• Kits
• Glycan labeling kits
• Glycan purification kits
• Glycan release kits
• Others
• Enzymes
• Glycosidases
• Glycosyl transferases
• Neuraminidases
• Sialyl transferases
• Others

Glycomics/Glycobiology Application Outlook (Revenue, USD Million; 2014 - 2025)

• Drug discovery & development
• Diagnostics
• Others

Glycomics/Glycobiology End-use Outlook (Revenue, USD Million; 2014 - 2025)

• Academic and research institutes
• Pharmaceutical and biotechnology companies 
• CROs

Glycomics/GlycobiologyRegional Outlook (Revenue, USD Million; 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• Japan
• China
• India
• Latin America
• Brazil
• Mexico
• MEA
• South Africa

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-glycomics-glycobiology-market              

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com